Paper7907677
Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II Study.
Lancet, 1994. Cited by 826 papers, by iCite.
Cite this record
ConductScience Library. Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II Study. Papers, record 7907677. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7907677
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Aspirin | Major topic |
| Atrial Fibrillation | Major topic |
| Cerebrovascular Disorders | Major topic |
| Thromboembolism | Major topic |
| Warfarin | Major topic |
| Aged | |
| Aged, 80 and over | |
| Follow-Up Studies | |
| Humans | |
| Risk Factors |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| R01-NS-24224 | NINDS NIH HHS | United States | R01NS024224 | PubMed and NIH |
Source NIH RePORTER
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT00281073 | Intra-Cardiac Echocardiography Guided Cardioversion(ICE-CHIP) Study | Background |
Source ClinicalTrials.gov
Comments and corrections3
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers | Source |
|---|---|---|---|---|
| Comment in | 7907673 | Aspirin or warfarin for non-rheumatic atrial fibrillation? | https://conductscience.org/library/papers/7907673 | PubMed |
| Comment in | 7911211 | Stroke Prevention in Atrial Fibrillation II Study. | https://conductscience.org/library/papers/7911211 | PubMed |
| Comment in | 7911213 | Stroke Prevention in Atrial Fibrillation II Study. | https://conductscience.org/library/papers/7911213 | PubMed |
Cited by213
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 826 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42253356 | Research Advances in Timing of Anticoagulant Therapy Following Cardioembolic Stroke. | Clin Med Insights Cardiol | 2026 | https://conductscience.org/library/papers/42253356 | PubMed |
| 41635420 | Extensive Intracerebral Hemorrhage Involving Basal Ganglia and Frontal Lobe With Intraventricular and Subarachnoid Extension in a Triplet Pregnancy Following In Vitro Fertilization: A Case Report and Review. | Clin Case Rep | 2026 | https://conductscience.org/library/papers/41635420 | PubMed |
| 41557516 | Effectiveness and Safety of Direct Oral Anticoagulants versus Aspirin in Patients with Non-Valvular Atrial Fibrillation and Intermediate Stroke Risk. | Clin Appl Thromb Hemost | 2026 | https://conductscience.org/library/papers/41557516 | PubMed |
| 41212662 | Association between first anticoagulant prescription and embolic and hemorrhagic events among older adults with atrial fibrillation. | J Intern Med | 2026 | https://conductscience.org/library/papers/41212662 | PubMed |
| 41181448 | Left atrial appendage closure versus anticoagulation in the management of atrial fibrillation: a systematic review, meta-analysis, and meta-regression analysis. | Ann Med Surg (Lond) | 2025 | https://conductscience.org/library/papers/41181448 | PubMed |
| 40843856 | First-Ever Stroke Outcomes in Patients with Atrial Fibrillation: A Retrospective Cross-Sectional Study. | Medicines (Basel) | 2025 | https://conductscience.org/library/papers/40843856 | PubMed |
| 40630456 | Anticoagulation for Stroke Prevention in Patients with Atrial Fibrillation: A Review of the Literature and Current Guidelines. | Rev Cardiovasc Med | 2025 | https://conductscience.org/library/papers/40630456 | PubMed |
| 39131471 | Left Atrial Appendage Occlusion: Current Stroke Prevention Strategies and a Shift Toward Data-Driven, Patient-Specific Approaches. | J Soc Cardiovasc Angiogr Interv | 2022 | https://conductscience.org/library/papers/39131471 | PubMed |
| 38813294 | Effectiveness of Anticoagulants in Reducing Stroke Risk Among Patients With Atrial Fibrillation. | Cureus | 2024 | https://conductscience.org/library/papers/38813294 | PubMed |
| 38525596 | Estimating Vitamin K Antagonist Anticoagulation Benefit in People With Atrial Fibrillation Accounting for Competing Risks: Evidence From 12 Randomized Trials. | Circ Cardiovasc Qual Outcomes | 2024 | https://conductscience.org/library/papers/38525596 | PubMed |
| 37887081 | Use of Oral Anticoagulants in Patients with Atrial Fibrillation: Preliminary Data from the Italian Atrial Fibrillation (ITALY-AF) Registry. | Clin Pract | 2023 | https://conductscience.org/library/papers/37887081 | PubMed |
| 37292062 | Persistence to rivaroxaban therapy for stroke prevention in clinical practice in Italy: Rationale and design of the RITMUS-AF prospective observational cohort study. | Int J Cardiol Heart Vasc | 2023 | https://conductscience.org/library/papers/37292062 | PubMed |
| 37119087 | Evaluation of Quantitative Decision-Making for Rhythm Management of Atrial Fibrillation Using Tabular Q-Learning. | J Am Heart Assoc | 2023 | https://conductscience.org/library/papers/37119087 | PubMed |
| 36670269 | Risk Factors for Anticoagulant-Associated Intracranial Hemorrhage: A Systematic Review and Meta-analysis. | Neurocrit Care | 2023 | https://conductscience.org/library/papers/36670269 | PubMed |
| 36342828 | Randomized Clinical Trial to Evaluate an Atrial Fibrillation Stroke Prevention Shared Decision-Making Pathway. | J Am Heart Assoc | 2023 | https://conductscience.org/library/papers/36342828 | PubMed |
| 35957664 | Application of fresh frozen plasma transfusion in the management of excessive warfarin-associated anticoagulation. | Blood Sci | 2022 | https://conductscience.org/library/papers/35957664 | PubMed |
| 35900898 | Antiplatelet agents and anticoagulants for hypertension. | Cochrane Database Syst Rev | 2022 | https://conductscience.org/library/papers/35900898 | PubMed |
| 35420918 | Cerebral Hemorrhage: Pathophysiology, Treatment, and Future Directions. | Circ Res | 2022 | https://conductscience.org/library/papers/35420918 | PubMed |
| 34874889 | Machine Learning Methodologies for Prediction of Rhythm-Control Strategy in Patients Diagnosed With Atrial Fibrillation: Observational, Retrospective, Case-Control Study. | JMIR Med Inform | 2021 | https://conductscience.org/library/papers/34874889 | PubMed |
| 34386117 | Atrial fibrillation in the elderly population: Challenges and management considerations. | J Arrhythm | 2021 | https://conductscience.org/library/papers/34386117 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Authors
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7907677
GET https://conductscience.org/api/papers/v1/7907677/cited_by?page=2